0
Rhythm Pharmaceuticals, Inc. Banner Image

Rhythm Pharmaceuticals, Inc. has reached its limit for free report views

Work for Rhythm Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Rhythm Pharmaceuticals, Inc.

  • Ticker RYTM
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Rhythm Pharmaceuticals, Inc. Logo Image
  • 51-200 Employees
  • Based in Boston, Massachusetts
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm’s lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).
Rhythm Pharmaceuticals, Inc.

Most Recent Annual Report

Rhythm Pharmaceuticals, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Rhythm Pharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports